Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Morphotek, Inc. Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins
Morphotek, 09/25/09

Morphotek, Inc., a subsidiary of Eisai Corporation of North America, announced that it was awarded $843,289 in funding from the National Institutes of Allergy and Infectious Diseases, part of the National Institutes of Health, to support the development of human monoclonal antibody therapies against staphylococcal–derived toxin(s)1.

Today in Popular Press...keeping you current

A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09

Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09

Astellas Inducted into National Minority Transplant Hall of Fame
Astellas, 12/09/09

 See all of Popular Press

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address